Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Mini-review: perspective of the microbiome in the pathogenesis of urothelial carcinoma.

About this Publication
Title
Mini-review: perspective of the microbiome in the pathogenesis of urothelial carcinoma.
Pubmed ID
25126590 (View this publication on the PubMed website)
Publication
Am J Clin Exp Urol. 2014 Apr; Volume 2 (Issue 1): Pages 57-61
Authors
Xu W, Yang L, Lee P, Huang WC, Nossa C, Ma Y, Deng FM, Zhou M, Melamed J, Pei Z
Affiliations
  • Department of Pathology, New York University School of Medicine, New York, NY.
  • Department of Medicine, New York University School of Medicine, New York, NY.
  • Department of Pathology, New York University School of Medicine, New York, NY ; Department of Urology, New York University School of Medicine, New York, NY ; Department of NYU Cancer Institute, New York University School of Medicine, New York, NY ; Department of Veterans Affairs New York Harbor Healthcare System, New York University School of Medicine, New York, NY.
  • Department of Urology, New York University School of Medicine, New York, NY.
  • Gene by Gene, Ltd. Houston, TX, USA.
  • Department of Pathology, New York University School of Medicine, New York, NY ; Department of NYU Cancer Institute, New York University School of Medicine, New York, NY.
  • Department of Pathology, New York University School of Medicine, New York, NY ; Department of Medicine, New York University School of Medicine, New York, NY ; Department of NYU Cancer Institute, New York University School of Medicine, New York, NY ; Department of Veterans Affairs New York Harbor Healthcare System, New York University School of Medicine, New York, NY.
Abstract

The microbiome is a new center of attention for studies on the pathogenesis of human disease by focusing on the alterations of all microorganisms living in a particular site or system of human body, referred as microbiota. Evidence suggests that microbiota could contribute to the pathogenesis of a number of chronic diseases, including cancers, both locally and remotely. Multiple mechanisms have been proposed and/or proven for the microbiota's role in tumorigenesis, such as via induction of chronic inflammation, genotoxicity, bacterium-mediated cell proliferation, and activation of procarcinogens. Emerging data suggest that indigenous microbiota in the urinary tract may play an important role in the tumorigenesis of urothelial carcinoma, similar to other tumors. Future studies are needed to adequately define the microbiota composition and correlate its change with urothelial carcinoma.

Related CDAS Studies
Related CDAS Projects